Question 1

Who owns RARE?

Accepted Answer

ULTRAGENYX PHARMACEUTICAL IN (RARE) is held by 157 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is BlackRock, Inc. as of Q1 2026.

Question 2

Are institutions buying or selling RARE?

Accepted Answer

In Q1 2026, 97 institutions opened or increased positions in ULTRAGENYX PHARMACEUTICAL IN while 68 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on RARE?

Accepted Answer

HoldingsIntel scores ULTRAGENYX PHARMACEUTICAL IN across four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) — with 4 of the 4 carrying data for RARE. In Q1 2026, the institutional leg showed net inflows: 97 buying versus 68 selling.

Question 4

How many hedge funds hold RARE?

Accepted Answer

157 institutional investors report holding ULTRAGENYX PHARMACEUTICAL IN (RARE) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into RARE?

Accepted Answer

As of Q1 2026, tracked institutions in ULTRAGENYX PHARMACEUTICAL IN show 97 buyers versus 68 sellers — net inflows.

Question 6

Are Congress members and hedge funds both buying RARE?

Accepted Answer

Yes — in the latest quarter, 1 members of Congress and 97 institutional investors bought ULTRAGENYX PHARMACEUTICAL IN. HoldingsIntel cross-checks STOCK Act disclosures against 13F filings to surface these overlaps.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
BlackRock, Inc.	Increased	7.3M(+10.1%)	$152.9M	0.0%	-34.66%	33
VPVANGUARD PORTFOLIO MANAGEMENT LLC	New	5.4M	$112.8M	0.0%	+16.99%	42
STATE STREET CORP	Increased	5M(+16.7%)	$105.2M	0.0%	-30.47%	35
AQR CAPITAL MANAGEMENT LLC	Increased	4.6M(+236.5%)	$95.9M	0.0%	+6.68%	48
VAVANGUARD CAPITAL MANAGEMENT LLC	New	4.2M	$87.8M	0.0%	+16.99%	41
RTW INVESTMENTS, LP	Increased	3.6M(+21.6%)	$76.4M	0.8%	-33.12%	50
SANDS CAPITAL MANAGEMENT, LLC	Decreased	3.2M(-7.8%)	$67.3M	0.3%	-43.15%	0
WELLINGTON MANAGEMENT GROUP LLP	Increased	2.6M(+7.3%)	$55.3M	0.0%	-34.20%	32
Assenagon Asset Management S.A.	Increased	2.3M(+1030.4%)	$47.3M	0.1%	-5.61%	47
TWO SIGMA INVESTMENTS, LP	Increased	2.2M(+420.2%)	$46.2M	0.0%	-0.04%	47
FRONTIER CAPITAL MANAGEMENT CO LLC	Increased	2.2M(+11.5%)	$45.9M	0.5%	-7.40%	39
CITADEL ADVISORS LLC	Decreased	2.1M(-9.1%)	$44.3M	0.0%	+7.29%	0
GEODE CAPITAL MANAGEMENT, LLC	Increased	1.8M(+0.6%)	$38.8M	0.0%	-49.31%	29
MILLENNIUM MANAGEMENT LLC	Increased	1.8M(+101.2%)	$37.1M	0.0%	+9.60%	47
MORGAN STANLEY	Decreased	1.5M(-17.8%)	$31.4M	0.0%	-14.83%	0
JACOBS LEVY EQUITY MANAGEMENT, INC	Decreased	1.4M(-18.2%)	$30M	0.1%	-17.30%	0
VOLORIDGE INVESTMENT MANAGEMENT, LLC	Increased	1.4M(+121.8%)	$29.9M	0.1%	+3.47%	56
DED. E. Shaw & Co., Inc.	Increased	1.3M(+265.8%)	$26.4M	0.0%	+0.51%	46
Candriam S.C.A.	Increased	1.1M(+37.1%)	$23M	0.1%	-30.84%	45
BANK OF AMERICA CORP /DE/	Decreased	1M(-13.8%)	$21.9M	0.0%	-19.55%	0

ULTRAGENYX PHARMACEUTICAL IN

Smart Money Verdict

Who's Trading

Continue exploring

Other Healthcare stocks held by institutions

ULTRAGENYX PHARMACEUTICAL IN

Smart Money Verdict

Who's Trading

Top Holders

Continue exploring

Other Healthcare stocks held by institutions